Merck & Co Inc
NYSE: MRK
$114.96
-$0.67 (-0.6%)
Closing Price on September 24, 2024
MRK Articles
Members of Dell Inc.’s (NYSE: DELL)Board of Directors have many distractions preventing them from reviving the struggling computer maker which help their back accounts and hurt the computer’s...
Published:
Concerns about the economy ran well ahead of those about the environment and the clean up in the Gulf. That should not be a surprise because there is a great deal of evidence about the economy...
Published:
GlaxoSmithKline (NYSE: GSK), like a number of pharmaceutical companies before it, has run up against the truth about one of its drugs. According to The New York Times, “In the fall of 1999, the...
Published:
Reuters: The US did not name China a currency manipulator. Reuters: Most money managers don’t believe the U.S. is in a double-dip recession — yet. Reuters: The IMF said housing and...
Published:
Merck & Co., Inc. (NYSE: MRK) will dump 16,000 workers now that its merger with Schering-Plough well along. The company announced plans to phase out operations at eight research sites and eight...
Published:
The problems in the Gulf have caused BP’s shares to drop from a 52-week high of $62 to the current price of $32. Two years ago, they were almost $70. BP’s stock is likely to surge again, and may...
Published:
Stocks may have bounced from their lows and gone lower of late, but there are still many down and out value stocks out there where shares may have been overly punished from the highs and with...
Published:
Last Updated:
There are three things investors traditionally want after making huge gains when they still want to hold stocks. They want stocks that have dividends and may want ‘value stocks.’ But the...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning: Canadian Solar, Inc. (NASDAQ: CSIQ) Raised to Buy but lowered...
Published:
Last Updated:
Reuters: Calm water is helping manage the Gulf oil spill. Reuters: April retail sales should be up in a sign of consumer recovery. Reuters: The US is questioning Johnson & Johnson’s...
Published:
Earnings season is slowly getting behind us for the regular quarter-end companies. But there are still many influential companies still reporting which can still move their respective sectors. ...
Published:
Last Updated:
We are seeing many key movers in the BioHealth space today as drug and biotech stocks often exhibit the most volatility of any sector. Today’s BioHealth Business Daily includes the key moves and...
Published:
Last Updated:
Reuters: Democrats may miss their goal to vote on healthcare reform. Reuters: China exports rose 46% in February. Reuters: China’s Geely raised money to buy Volvo. Reuters: Strong...
Published:
Toyota (TM) got a small taste of things to come. The company already faces a raft of class action and liability suits. Now, a suit which involves the crash of a Lexus ES 350 after it mysteriously...
Published:
There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total annual sales of over $500 billion. The firms have...
Published: